Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?-Reference-Cited by-同舟云学术

Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?

Published:2016-06-30 Issue:6 Volume:11 Page:e0158604
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tavernier Elsa,Trinquart Ludovic,Giraudeau Bruno

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Doing New Research? Don’t Forget the Old;M Clarke;PLoS Med,2004

2. What makes clinical research ethical?;EJ Emanuel;JAMA,2000

3. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group;Stat Med,1999

4. Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review;T Clark;BMJ,2013

5. Underpowering in randomized trials reporting a sample size calculation;AJ Vickers;J Clin Epidemiol,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies;British Journal of Clinical Pharmacology;2022-02-20

2. Awake prone positioning in COVID-19: is tummy time ready for prime time?;The Lancet Respiratory Medicine;2021-12

3. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial;The Lancet Respiratory Medicine;2021-12

4. A critical moment for health care;The Lancet Respiratory Medicine;2021-12

5. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): Protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies;British Journal of Clinical Pharmacology;2021-01-19